167 related articles for article (PubMed ID: 11557735)
1. Increased expression and activity of RhoA are associated with increased DNA synthesis and reduced p27(Kip1) expression in the vasculature of hypertensive rats.
Seasholtz TM; Zhang T; Morissette MR; Howes AL; Yang AH; Brown JH
Circ Res; 2001 Sep; 89(6):488-95. PubMed ID: 11557735
[TBL] [Abstract][Full Text] [Related]
2. Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle.
Seko T; Ito M; Kureishi Y; Okamoto R; Moriki N; Onishi K; Isaka N; Hartshorne DJ; Nakano T
Circ Res; 2003 Mar; 92(4):411-8. PubMed ID: 12600888
[TBL] [Abstract][Full Text] [Related]
3. 3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing rho GTPase-induced down-regulation of p27(Kip1).
Laufs U; Marra D; Node K; Liao JK
J Biol Chem; 1999 Jul; 274(31):21926-31. PubMed ID: 10419514
[TBL] [Abstract][Full Text] [Related]
4. Salicylates dilate blood vessels through inhibiting PYK2-mediated RhoA/Rho-kinase activation.
Ying Z; Giachini FR; Tostes RC; Webb RC
Cardiovasc Res; 2009 Jul; 83(1):155-62. PubMed ID: 19276129
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II regulates the cell cycle of vascular smooth muscle cells from SHR.
Kubo A; Fukuda N; Teng J; Satoh C; Nakayama M; Kishioka H; Kanmatsuse K
Am J Hypertens; 2000 Oct; 13(10):1117-24. PubMed ID: 11041167
[TBL] [Abstract][Full Text] [Related]
6. Ontogenetic changes in contribution of calcium sensitization and calcium entry to blood pressure maintenance of Wistar-Kyoto and spontaneously hypertensive rats.
Behuliak M; Vavřínová A; Bencze M; Polgárová K; Ergang P; Kuneš J; Vaněčková I; Zicha J
J Hypertens; 2015 Dec; 33(12):2443-54. PubMed ID: 26418671
[TBL] [Abstract][Full Text] [Related]
7. Oxidized LDL induces proliferation and hypertrophy in human umbilical vein endothelial cells via regulation of p27Kip1 expression: role of RhoA.
Seibold S; Schürle D; Heinloth A; Wolf G; Wagner M; Galle J
J Am Soc Nephrol; 2004 Dec; 15(12):3026-34. PubMed ID: 15579505
[TBL] [Abstract][Full Text] [Related]
8. RhoA activation in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats.
Moriki N; Ito M; Seko T; Kureishi Y; Okamoto R; Nakakuki T; Kongo M; Isaka N; Kaibuchi K; Nakano T
Hypertens Res; 2004 Apr; 27(4):263-70. PubMed ID: 15127884
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Ca2+-dependent activation of phosphoinositide 3-kinase class IIα isoform-Rho axis in blood vessels of spontaneously hypertensive rats.
Seok YM; Azam MA; Okamoto Y; Sato A; Yoshioka K; Maeda M; Kim I; Takuwa Y
Hypertension; 2010 Nov; 56(5):934-41. PubMed ID: 20921425
[TBL] [Abstract][Full Text] [Related]
10. p27Kip1 modulates cell migration through the regulation of RhoA activation.
Besson A; Gurian-West M; Schmidt A; Hall A; Roberts JM
Genes Dev; 2004 Apr; 18(8):862-76. PubMed ID: 15078817
[TBL] [Abstract][Full Text] [Related]
11. Progesterone induces RhoA Inactivation in male rat aortic smooth muscle cells through up-regulation of p27(kip1.).
Wang HC; Lee WS
Endocrinology; 2014 Nov; 155(11):4473-82. PubMed ID: 25137028
[TBL] [Abstract][Full Text] [Related]
12. Negative regulation of RhoA/Rho kinase by angiotensin II type 2 receptor in vascular smooth muscle cells: role in angiotensin II-induced vasodilation in stroke-prone spontaneously hypertensive rats.
Savoia C; Tabet F; Yao G; Schiffrin EL; Touyz RM
J Hypertens; 2005 May; 23(5):1037-45. PubMed ID: 15834290
[TBL] [Abstract][Full Text] [Related]
13. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases.
Touyz RM; Yao G
J Cell Physiol; 2003 Dec; 197(3):326-35. PubMed ID: 14566962
[TBL] [Abstract][Full Text] [Related]
14. Hemin inhibits hypertensive rat vascular smooth muscle cell proliferation through regulation of cyclin D and p21.
Jeon EM; Choi HC; Lee KY; Chang KC; Kang YJ
Arch Pharm Res; 2009 Mar; 32(3):375-82. PubMed ID: 19387581
[TBL] [Abstract][Full Text] [Related]
15. Vascular smooth muscle cell growth and insulin regulation of mitogen-activated protein kinase in hypertension.
Begum N; Song Y; Rienzie J; Ragolia L
Am J Physiol; 1998 Jul; 275(1):C42-9. PubMed ID: 9688833
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation.
Tanner FC; Boehm M; Akyürek LM; San H; Yang ZY; Tashiro J; Nabel GJ; Nabel EG
Circulation; 2000 May; 101(17):2022-5. PubMed ID: 10790340
[TBL] [Abstract][Full Text] [Related]
17. p27(Kip1) is important in modulating pulmonary artery smooth muscle cell proliferation.
Fouty BW; Grimison B; Fagan KA; Le Cras TD; Harral JW; Hoedt-Miller M; Sclafani RA; Rodman DM
Am J Respir Cell Mol Biol; 2001 Nov; 25(5):652-8. PubMed ID: 11713109
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of vascular smooth muscle cell proliferation by sodium salicylate mediated by upregulation of p21(Waf1) and p27(Kip1).
Marra DE; Simoncini T; Liao JK
Circulation; 2000 Oct; 102(17):2124-30. PubMed ID: 11044431
[TBL] [Abstract][Full Text] [Related]
19. Different cell cycle regulation of vascular smooth muscle in genetic hypertension.
Tanner FC; Greutert H; Barandier C; Frischknecht K; Lüscher TF
Hypertension; 2003 Aug; 42(2):184-8. PubMed ID: 12847112
[TBL] [Abstract][Full Text] [Related]
20. Impaired peroxisome proliferator-activated receptor-gamma contributes to phenotypic modulation of vascular smooth muscle cells during hypertension.
Zhang L; Xie P; Wang J; Yang Q; Fang C; Zhou S; Li J
J Biol Chem; 2010 Apr; 285(18):13666-77. PubMed ID: 20212046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
